U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2018
436
Substance Class Protein
Created
by admin
on Sat Dec 16 16:04:17 GMT 2023
Edited
by admin
on Sat Dec 16 16:04:17 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
6QVL057INT
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
CEMIPLIMAB
USAN   INN  
Official Name English
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Common Name English
CEMIPLIMAB [USAN]
Common Name English
Cemiplimab [WHO-DD]
Common Name English
cemiplimab [INN]
Common Name English
CEMIPLIMAB [MI]
Common Name English
CEMIPLIMAB [JAN]
Common Name English
REGN2810
Code English
REGN-2810
Code English
Classification Tree Code System Code
NCI_THESAURUS C128037
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
NCI_THESAURUS C129822
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
Code System Code Type Description
LACTMED
Cemiplimab
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
PRIMARY
CAS
1801342-60-8
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
PRIMARY
DAILYMED
6QVL057INT
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
PRIMARY
USAN
DE-88
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
PRIMARY
RXCUI
2058825
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
ALTERNATIVE
DRUG CENTRAL
5317
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
PRIMARY
DRUG BANK
DB14707
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
PRIMARY
MERCK INDEX
m12112
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
PRIMARY
WIKIPEDIA
Cemiplimab
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
PRIMARY
FDA UNII
6QVL057INT
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
PRIMARY
NCI_THESAURUS
C121540
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
PRIMARY
SMS_ID
100000175258
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
PRIMARY
RXCUI
2058826
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
PRIMARY
INN
10691
Created by admin on Sat Dec 16 16:04:17 GMT 2023 , Edited by admin on Sat Dec 16 16:04:17 GMT 2023
PRIMARY
From To
1_22 1_96
1_144 1_200
1_258 1_318
1_364 1_422
1_131 3_214
1_223 2_223
1_226 2_226
2_22 2_96
2_144 2_200
2_258 2_318
2_364 2_422
2_131 4_214
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_294
N 2_294
Related Record Type Details
CEMIPLIMAB-RWLC
SUB_CONCEPT->SUBSTANCE
CEMIPLIMAB-RWLC
INNOVATOR->PARENT
PROGRAMMED CELL DEATH PROTEIN 1
TARGET -> INHIBITOR
Related Record Type Details
CEMIPLIMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966